GlassScriptPhysician profile
William Tatum
NPI 1396764122
$27,928.39
in general payments reported to CMS, 2019-2025
12 companies · $3,087 in 2025
The $3,087 reported for 2025 was more than what 82% of Epilepsy providers received nationally (typical 2025 total: $366).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,275 · 2021: $170 · 2022: $9,617 · 2023: $573 · 2024: $13K · 2025: $3,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $808 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,642.00 |
| Food and Beverage | $807.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $417.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $23,489.36 | 2022-2025 | Valtoco |
| Medtronic USA, INC. | $1,275.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $1,106.44 | 2021-2024 | Rosa |
| Natus Medical Incorporated | $1,000.00 | 2022 | |
| Livanova USA, INC. | $417.00 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic, INC. | $208.89 | 2022-2025 | Percept PC Brainsense |
| Cadwell Industries, INC | $156.00 | 2023 | |
| Neuropace, INC. | $146.63 | 2024 | |
| Sk Life Science, INC. | $129.07 | 2025 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Tatum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.